lunes, 10 de enero de 2022

The benefits, costs and feasibility of a low incidence COVID-19 strategy - The Lancet Regional Health – Europe

The benefits, costs and feasibility of a low incidence COVID-19 strategy - The Lancet Regional Health – Europe

No hay comentarios: